Drugs / rF-CEA(6D)-TRICOM
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00081848 | Apr 2004 → Aug 2007 | liver and intrahepatic bile duct neoplasm | National Cancer Institute (NCI) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rF-CEA(6D)-TRICOM | “a "boosting vaccine" called rF-CEA(6D)-TRICOM), made from fowlpox virus” NCT00081848 ↗ |
| Modality | Vaccine | “a "boosting vaccine" called rF-CEA(6D)-TRICOM), made from fowlpox virus” NCT00081848 ↗ |
| Route | Subcutaneous | “rF-CEA(6D)/TRICOM, (4 x 10(8)) PFU s.c., days 21, 35, 49, and 63” NCT00081848 ↗ |